Health

Alyra Biotech | Intrauterine Contraceptive Devices Survey.

Apr 7, 2021 | Reading Time: 2 minutes

ALYRA BIOTECH IS SEEKING WOMEN’S PERSPECTIVES, EXPERIENCES AND PREFERENCES OF INTRAUTERINE CONTRACEPTIVE DEVICES.  BY PARTICIPATING, YOU MAY BE HELPING TO IMPROVE HEALTH OUTCOMES FOR WOMEN.

At She Shopped, we are committed to acts of service – and this time, our act of service doesn’t involve donating to charity but playing a small role in collecting data that may improve health outcomes for women.

She Shopped founder, Lucy Cornes, came across this survey through her role as a board member for the Pelvic Pain Foundation of Australia.  The Australian company behind the survey Alyra Biotech are committed to improving the lives of women in pain.

Alyra Biotech are inviting you to participate in their consumer research to help them understand your thoughts, views and experiences of intrauterine contraceptive devices.

They are also interested to hear about your experience of period or pelvic pain before and after having an intrauterine contraceptive device inserted or concerns about this and having one inserted.

Your answers will remain anonymous.

Many women around the world choose to use intrauterine contraceptive device for contraception. Unfortunately, a small but significant number of women experience additional pain in their pelvic region either upon insertion and/or similar pain for up to 3 months following insertion.

Alyra Biotech is interested in understanding your experiences and concerns about having an intrauterine contraceptive device in the present or future. They would also like to determine whether you would consider having an intrauterine contraceptive device inserted if you knew that it could reduce your pelvic and/or period pain by approximately 50% for up to 3 months following insertion. More important considerations for this study are:

  • out-of-pocket costs,
  • what would be affordable, and
  • hearing your views on what the ideal intrauterine contraceptive device would provide to you.

It is their vision that your views will help them design new intrauterine contraceptive devices that may suit women with specific health needs. This is an unmet medical need requiring patient-focused medical product development. Your anonymous answers in this survey will help Alyra Biotech understand consumers’ needs during the conceptual phase of developing new intrauterine contraceptive devices that effectively manage period and pelvic pain.

If you are interested to find out more information about this research, or to participate in the survey, please select the following link https://www.surveymonkey.com/r/H6L6L9K

Thank you for considering participating in this survey.   Your responses are so very valuable to Alyra Biotech.

 

Pin It on Pinterest

Share This